Certain patients undergoing total joint arthroplasty procedures have a very low chance of receiving a blood transfusion in the perioperative period. These patients may not need to donate autologous blood.
Rationale:
(1) The National Heart, Lung and Blood Institute Expert Panel on the Use of Autologous Blood has recommended that patients with < 10% chance of needing a perioperative transfusion should not be encouraged to donate autologous blood.
(2) A large percentage (56% of units in the study population) of the autologous products are discarded.
Factors with an increased risk for blood transfusion:
(1) revision knee or hip procedure
(2) one-stage bilateral primary knee replacement
(3) initial hemoglobin < 130 g/L
(4) age >= 65
Groups with Very Low Chance of Perioperative Transfusion
Group 1:
(1) hemoglobin >= 150 g/L
(2) unilateral primary arthroplasty
Group 2:
(1) hemoglobin 130 – 150 g/L
(2) age < 65 years of age
(3) unilateral primary arthroplasty
NOTE: These findings are similar to those described above in 05.01.02.
Purpose: To identify patients undergoing total joint arthroplasty with a very low risk of needing a perioperative blood transfusion.
Specialty: Clinical Laboratory, Surgery, general, Anesthesiology, Emergency Medicine, Critical Care
Objective: risk factors, severity, prognosis, stage, complications, selection
ICD-10: M15-M19, Z51.3,